Spatiotemporal 16p11.2 Protein Network Implicates Cortical Late Mid-Fetal Brain Development and KCTD13-Cul3-RhoA Pathway in Psychiatric Diseases

Neuron

Volumn 85, Issue 4, 2015, Pages 742-754

  Lin, Guan Ning ^a   Corominas, Roser ^a   Lemmens, Irma ^b   Yang, Xinping ^c   Tavernier, Jan ^b   Hill, David E ^c   Vidal, Marc ^c   Sebat, Jonathan ^a   Iakoucheva, Lilia M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GHENT UNIVERSITY   (Belgium)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CULIN 3; KCTD10 PROTEIN; KCTD13 PROTEIN; NERVE GROWTH FACTOR RECEPTOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; CUL3 PROTEIN, HUMAN; CULLIN; KCTD13 PROTEIN, HUMAN; NUCLEAR PROTEIN;

ADULT; AGED; ARTICLE; AUTISM; BIPOLAR DISORDER; BRAIN DEVELOPMENT; BRAIN SIZE; CELL MIGRATION; CHILD; CHROMOSOME; CHROMOSOME 16P11; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CONNECTOME; CONTROLLED STUDY; COPY NUMBER VARIATION; CUL3 GENE; DENDRITIC SPINE; DEVELOPMENTAL STAGE; DNA REPLICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTELLECTUAL IMPAIRMENT; KCTD13 GENE; MENTAL DISEASE; NERVE FIBER GROWTH; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RHOA GENE; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SPATIOTEMPORAL ANALYSIS; UBIQUITINATION; VERY ELDERLY; ADOLESCENT; BRAIN; CHROMOSOME 16; EMBRYOLOGY; FETUS; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; GLIA; GROWTH, DEVELOPMENT AND AGING; INFANT; METABOLISM; NERVE CELL; NEWBORN; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED, 80 AND OVER; BRAIN; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 16; CULLIN PROTEINS; DNA COPY NUMBER VARIATIONS; FETUS; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; INFANT; INFANT, NEWBORN; MENTAL DISORDERS; NEUROGLIA; NEURONS; NUCLEAR PROTEINS; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84925451823     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2015.01.010     Document Type: Article

References (64)

1. Bijlsma E.K., Gijsbers A.C., Schuurs-Hoeijmakers J.H., van Haeringen A., Fransen van de Putte D.E., Anderlid B.M., Lundin J., Lapunzina P., Pérez Jurado L.A., Delle Chiaie B., et al. Extending the phenotype of recurrent rearrangements of 16p11.2: deletions in mentally retarded patients without autism and in normal individuals. Eur. J. Med. Genet. 2009, 52:77-87.
2. Chatr-Aryamontri A., Breitkreutz B.J., Heinicke S., Boucher L., Winter A., Stark C., Nixon J., Ramage L., Kolas N., O'Donnell L., et al. The BioGRID interaction database: 2013 update. Nucleic Acids Res. 2013, 41:D816-D823.
3. Chen L., Melendez J., Campbell K., Kuan C.Y., Zheng Y. Rac1 deficiency in the forebrain results in neural progenitor reduction and microcephaly. Dev. Biol. 2009, 325:162-170.
4. Chen Y., Yang Z., Meng M., Zhao Y., Dong N., Yan H., Liu L., Ding M., Peng H.B., Shao F. Cullin mediates degradation of RhoA through evolutionarily conserved BTB adaptors to control actin cytoskeleton structure and cell movement. Mol. Cell 2009, 35:841-855.
5. Consortium I.S. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455:237-241. International Schizophrenia Consortium.
6. Cooper G.M., Coe B.P., Girirajan S., Rosenfeld J.A., Vu T.H., Baker C., Williams C., Stalker H., Hamid R., Hannig V., et al. A copy number variation morbidity map of developmental delay. Nat. Genet. 2011, 43:838-846.
7. Corominas R., Yang X., Lin G.N., Kang S., Shen Y., Ghamsari L., Broly M., Rodriguez M., Tam S., Trigg S.A., et al. Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism. Nat. Commun. 2014, 5:3650.
8. de Lichtenberg U., Jensen L.J., Brunak S., Bork P. Dynamic complex formation during the yeast cell cycle. Science 2005, 307:724-727.
9. Fromer M., Pocklington A.J., Kavanagh D.H., Williams H.J., Dwyer S., Gormley P., Georgieva L., Rees E., Palta P., Ruderfer D.M., et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014, 506:179-184.
10. Ge H., Liu Z., Church G.M., Vidal M. Correlation between transcriptome and interactome mapping data from Saccharomyces cerevisiae. Nat. Genet. 2001, 29:482-486.
11. Genschik P., Sumara I., Lechner E. The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications. EMBO J. 2013, 32:2307-2320.
12. Gilman S.R., Iossifov I., Levy D., Ronemus M., Wigler M., Vitkup D. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 2011, 70:898-907.
13. Girirajan S., Rosenfeld J.A., Coe B.P., Parikh S., Friedman N., Goldstein A., Filipink R.A., McConnell J.S., Angle B., Meschino W.S., et al. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N.Engl. J. Med. 2012, 367:1321-1331.
14. Golzio C., Willer J., Talkowski M.E., Oh E.C., Taniguchi Y., Jacquemont S., Reymond A., Sun M., Sawa A., Gusella J.F., et al. KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant. Nature 2012, 485:363-367.
15. Govek E.E., Hatten M.E., Van Aelst L. The role of Rho GTPase proteins in CNS neuronal migration. Dev. Neurobiol. 2011, 71:528-553.
16. Grigoriev A. A relationship between gene expression and protein interactions on the proteome scale: analysis of the bacteriophage T7 and the yeast Saccharomyces cerevisiae. Nucleic Acids Res. 2001, 29:3513-3519.
17. Gulsuner S., Walsh T., Watts A.C., Lee M.K., Thornton A.M., Casadei S., Rippey C., Shahin H., Nimgaonkar V.L., Go R.C., et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 2013, 154:518-529. Consortium on the Genetics of Schizophrenia (COGS), PAARTNERS Study GroupPAARTNERS Study Group.
18. Harrow J., Frankish A., Gonzalez J.M., Tapanari E., Diekhans M., Kokocinski F., Aken B.L., Barrell D., Zadissa A., Searle S., et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 2012, 22:1760-1774.
19. He H., Tan C.K., Downey K.M., So A.G. A tumor necrosis factor alpha- and interleukin 6-inducible protein that interacts with the small subunit of DNA polymerase delta and proliferating cell nuclear antigen. Proc. Natl. Acad. Sci. USA 2001, 98:11979-11984.
20. Horev G., Ellegood J., Lerch J.P., Son Y.E., Muthuswamy L., Vogel H., Krieger A.M., Buja A., Henkelman R.M., Wigler M., Mills A.A. Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism. Proc. Natl. Acad. Sci. USA 2011, 108:17076-17081.
21. Iossifov I., Ronemus M., Levy D., Wang Z., Hakker I., Rosenbaum J., Yamrom B., Lee Y.H., Narzisi G., Leotta A., et al. De novo gene disruptions in children on the autistic spectrum. Neuron 2012, 74:285-299.
22. Jansen R., Greenbaum D., Gerstein M. Relating whole-genome expression data with protein-protein interactions. Genome Res. 2002, 12:37-46.
23. Kang H.J., Kawasawa Y.I., Cheng F., Zhu Y., Xu X., Li M., Sousa A.M., Pletikos M., Meyer K.A., Sedmak G., et al. Spatio-temporal transcriptome of the human brain. Nature 2011, 478:483-489.
24. Kirov G., Grozeva D., Norton N., Ivanov D., Mantripragada K.K., Holmans P., Craddock N., Owen M.J., O'Donovan M.C. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum. Mol. Genet. 2009, 18:1497-1503. International Schizophrenia Consortium, Wellcome Trust Case Control ConsortiumWellcome Trust Case Control Consortium.
25. Kitchen R.R., Rozowsky J.S., Gerstein M.B., Nairn A.C. Decoding neuroproteomics: integrating the genome, translatome and functional anatomy. Nat. Neurosci. 2014, 17:1491-1499.
26. Kong A., Frigge M.L., Masson G., Besenbacher S., Sulem P., Magnusson G., Gudjonsson S.A., Sigurdsson A., Jonasdottir A., Jonasdottir A., et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature 2012, 488:471-475.
27. Krey J.F., Paşca S.P., Shcheglovitov A., Yazawa M., Schwemberger R., Rasmusson R., Dolmetsch R.E. Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons. Nat. Neurosci. 2013, 16:201-209.
28. Levy D., Ronemus M., Yamrom B., Lee Y.H., Leotta A., Kendall J., Marks S., Lakshmi B., Pai D., Ye K., et al. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 2011, 70:886-897.
29. Lionel A.C., Crosbie J., Barbosa N., Goodale T., Thiruvahindrapuram B., Rickaby J., Gazzellone M., Carson A.R., Howe J.L., Wang Z., et al. Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci. Transl. Med. 2011, 3:95ra75.
30. Luo R., Sanders S.J., Tian Y., Voineagu I., Huang N., Chu S.H., Klei L., Cai C., Ou J., Lowe J.K., et al. Genome-wide transcriptome profiling reveals the functional impact of rare de novo and recurrent CNVs in autism spectrum disorders. Am. J. Hum. Genet. 2012, 91:38-55.
31. Luscombe N.M., Babu M.M., Yu H., Snyder M., Teichmann S.A., Gerstein M. Genomic analysis of regulatory network dynamics reveals large topological changes. Nature 2004, 431:308-312.
32. Malhotra D., Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 2012, 148:1223-1241.
33. Malhotra D., McCarthy S., Michaelson J.J., Vacic V., Burdick K.E., Yoon S., Cichon S., Corvin A., Gary S., Gershon E.S., et al. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 2011, 72:951-963.
34. Marshall C.R., Noor A., Vincent J.B., Lionel A.C., Feuk L., Skaug J., Shago M., Moessner R., Pinto D., Ren Y., et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 2008, 82:477-488.
35. McCarthy S.E., Makarov V., Kirov G., Addington A.M., McClellan J., Yoon S., Perkins D.O., Dickel D.E., Kusenda M., Krastoshevsky O., et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat. Genet. 2009, 41:1223-1227. Wellcome Trust Case Control Consortium.
36. Merikangas A.K., Corvin A.P., Gallagher L. Copy-number variants in neurodevelopmental disorders: promises and challenges. Trends Genet. 2009, 25:536-544.
37. Miller J.A., Ding S.L., Sunkin S.M., Smith K.A., Ng L., Szafer A., Ebbert A., Riley Z.L., Royall J.J., Aiona K., et al. Transcriptional landscape of the prenatal human brain. Nature 2014, 508:199-206.
38. Mills R.E., Walter K., Stewart C., Handsaker R.E., Chen K., Alkan C., Abyzov A., Yoon S.C., Ye K., Cheetham R.K., et al. Mapping copy number variation by population-scale genome sequencing. Nature 2011, 470:59-65. 1000 Genomes Project.
39. Mulle J.G., Dodd A.F., McGrath J.A., Wolyniec P.S., Mitchell A.A., Shetty A.C., Sobreira N.L., Valle D., Rudd M.K., Satten G., et al. Microdeletions of 3q29 confer high risk for schizophrenia. Am. J. Hum. Genet. 2010, 87:229-236.
40. Mulle J.G., Pulver A.E., McGrath J.A., Wolyniec P.S., Dodd A.F., Cutler D.J., Sebat J., Malhotra D., Nestadt G., Conrad D.F., et al. Reciprocal duplication of the Williams-Beuren syndrome deletion on chromosome 7q11.23 is associated with schizophrenia. Biol. Psychiatry 2014, 75:371-377. Molecular Genetics of Schizophrenia Consortium.
41. Noh H.J., Ponting C.P., Boulding H.C., Meader S., Betancur C., Buxbaum J.D., Pinto D., Marshall C.R., Lionel A.C., Scherer S.W., Webber C. Network topologies and convergent aetiologies arising from deletions and duplications observed in individuals with autism. PLoS Genet. 2013, 9:e1003523.
42. O'Roak B.J., Vives L., Girirajan S., Karakoc E., Krumm N., Coe B.P., Levy R., Ko A., Lee C., Smith J.D., et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485:246-250.
43. Parikshak N.N., Luo R., Zhang A., Won H., Lowe J.K., Chandran V., Horvath S., Geschwind D.H. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 2013, 155:1008-1021.
44. Pinto D., Pagnamenta A.T., Klei L., Anney R., Merico D., Regan R., Conroy J., Magalhaes T.R., Correia C., Abrahams B.S., et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010, 466:368-372.
45. Portmann T., Yang M., Mao R., Panagiotakos G., Ellegood J., Dolen G., Bader P.L., Grueter B.A., Goold C., Fisher E., et al. Behavioral abnormalities and circuit defects in the basal ganglia of a mouse model of 16p11.2 deletion syndrome. Cell Rep. 2014, 7:1077-1092.
46. Pujana M.A., Han J.D., Starita L.M., Stevens K.N., Tewari M., Ahn J.S., Rennert G., Moreno V., Kirchhoff T., Gold B., et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat. Genet. 2007, 39:1338-1349.
47. Rolland T., Taşan M., Charloteaux B., Pevzner S.J., Zhong Q., Sahni N., Yi S., Lemmens I., Fontanillo C., Mosca R., et al. A proteome-scale map of the human interactome network. Cell 2014, 159:1212-1226.
48. Sanders S.J., Ercan-Sencicek A.G., Hus V., Luo R., Murtha M.T., Moreno-De-Luca D., Chu S.H., Moreau M.P., Gupta A.R., Thomson S.A., et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011, 70:863-885.
49. Sebat J., Lakshmi B., Malhotra D., Troge J., Lese-Martin C., Walsh T., Yamrom B., Yoon S., Krasnitz A., Kendall J., et al. Strong association of de novo copy number mutations with autism. Science 2007, 316:445-449.
50. Segal E., Wang H., Koller D. Discovering molecular pathways from protein interaction and gene expression data. Bioinformatics 2003, 19(Suppl 1):i264-i271.
51. Shapiro E., Biezuner T., Linnarsson S. Single-cell sequencing-based technologies will revolutionize whole-organism science. Nat. Rev. Genet. 2013, 14:618-630.
52. Stark C., Breitkreutz B.J., Reguly T., Boucher L., Breitkreutz A., Tyers M. BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 2006, 34:D535-D539.
53. Stefansson H., Rujescu D., Cichon S., Pietiläinen O.P., Ingason A., Steinberg S., Fossdal R., Sigurdsson E., Sigmundsson T., Buizer-Voskamp J.E., et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455:232-236. GROUP.
54. Stoner R., Chow M.L., Boyle M.P., Sunkin S.M., Mouton P.R., Roy S., Wynshaw-Boris A., Colamarino S.A., Lein E.S., Courchesne E. Patches of disorganization in the neocortex of children with autism. N.Engl. J. Med. 2014, 370:1209-1219.
55. Walker B.A., Ji S.J., Jaffrey S.R. Intra-axonal translation of RhoA promotes axon growth inhibition by CSPG. J.Neurosci. 2012, 32:14442-14447.
56. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320:539-543.
57. Wang Y., Zheng Y., Luo F., Fan X., Chen J., Zhang C., Hui R. KCTD10 interacts with proliferating cell nuclear antigen and its down-regulation could inhibit cell proliferation. J.Cell. Biochem. 2009, 106:409-413.
58. Weiss L.A., Shen Y., Korn J.M., Arking D.E., Miller D.T., Fossdal R., Saemundsen E., Stefansson H., Ferreira M.A., Green T., et al. Association between microdeletion and microduplication at 16p11.2 and autism. N.Engl. J. Med. 2008, 358:667-675. Autism Consortium.
59. Willsey A.J., Sanders S.J., Li M., Dong S., Tebbenkamp A.T., Muhle R.A., Reilly S.K., Lin L., Fertuzinhos S., Miller J.A., et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 2013, 155:997-1007.
60. Yang L., Liu N., Hu X., Zhang W., Wang T., Li H., Zhang B., Xiang S., Zhou J., Zhang J. CK2 phosphorylates TNFAIP1 to affect its subcellular localization and interaction with PCNA. Mol. Biol. Rep. 2010, 37:2967-2973.
61. Yang X., Boehm J.S., Yang X., Salehi-Ashtiani K., Hao T., Shen Y., Lubonja R., Thomas S.R., Alkan O., Bhimdi T., et al. A public genome-scale lentiviral expression library of human ORFs. Nat. Methods 2011, 8:659-661.
62. Zhang H., Macara I.G. The PAR-6 polarity protein regulates dendritic spine morphogenesis through p190 RhoGAP and the Rho GTPase. Dev. Cell 2008, 14:216-226.
63. Zhong Q., Simonis N., Li Q.R., Charloteaux B., Heuze F., Klitgord N., Tam S., Yu H., Venkatesan K., Mou D., et al. Edgetic perturbation models of human inherited disorders. Mol. Syst. Biol. 2009, 5:321.
64. Zhu S., Korzh V., Gong Z., Low B.C. RhoA prevents apoptosis during zebrafish embryogenesis through activation of Mek/Erk pathway. Oncogene 2008, 27:1580-1589.